The Ad Council’s Some Things Come with Age videos come in both Spanish and English so as to be culturally relevant in helping people notice signs of Alzheimer’s.
New Alzheimer’s drug raises hopes — along with questions
The full Phase 3 data are sure to fuel debate about the relative merits of donanemab’s rapid plaque clearing versus rival Leqembi’s cleaner safety profile.
Acumen’s topline results stoke interest in early Alzheimer’s treatment
This week the FDA is expected to approve what many scientists and doctors believe is the first drug to show promise of slowing the progression of Alzheimer’s disease.
FDA adcomm recommends Alzheimer’s drug Leqembi for full approval